The results demonstrated that Cav-1 reduced the concentrations of Fe2+ in the liver tissue to alleviate the development of NAFLD by up-regulating the FTL/FTH pathway. This evidence concerns the gene FTH1 and metabolic dysfunction-associated steatotic liver disease.